Recordati Industria Chimica e Farmaceutica Balance Sheet Health
Financial Health criteria checks 3/6
Recordati Industria Chimica e Farmaceutica has a total shareholder equity of €1.8B and total debt of €1.6B, which brings its debt-to-equity ratio to 91.1%. Its total assets and total liabilities are €4.2B and €2.4B respectively. Recordati Industria Chimica e Farmaceutica's EBIT is €654.7M making its interest coverage ratio 8.3. It has cash and short-term investments of €200.6M.
Key information
91.1%
Debt to equity ratio
€1.64b
Debt
| Interest coverage ratio | 8.3x |
| Cash | €200.58m |
| Equity | €1.80b |
| Total liabilities | €2.40b |
| Total assets | €4.20b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: RCDT.F's short term assets (€1.2B) exceed its short term liabilities (€887.2M).
Long Term Liabilities: RCDT.F's short term assets (€1.2B) do not cover its long term liabilities (€1.5B).
Debt to Equity History and Analysis
Debt Level: RCDT.F's net debt to equity ratio (80%) is considered high.
Reducing Debt: RCDT.F's debt to equity ratio has increased from 68.5% to 91.1% over the past 5 years.
Debt Coverage: RCDT.F's debt is well covered by operating cash flow (29.3%).
Interest Coverage: RCDT.F's interest payments on its debt are well covered by EBIT (8.3x coverage).